AMPLI1
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AMPLI1 Trademark

Serial Number: 79310062 • Registration: 6617366

AMPLI1 is a trademark filed by Menarini Silicon Biosystems S.p.A. on February 2, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Menarini Silicon Biosystems S.p.A. (17 trademarks)

Via Giuseppe di Vittorio 21 B/3
Castel Maggiore BO 40013 , IT

Entity Type: 09

Trademark Details

Filing Date

February 2, 2021

Registration Date

January 18, 2022

Published for Opposition

November 2, 2021

Goods & Services

Diagnostic kits composed of diagnostic agents, preparations and substances for medical use in disease testing; diagnostic preparations and materials, namely, diagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical purposes; clinical medical reagents; clinical diagnostic medical reagents; diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests for medical purposes; nucleic acid sequences for medical and veterinary purposes; reagents for in-vitro laboratory use being reagents for medical purposes

Chemical reagents for molecular biology not for medical or veterinary purposes; reagents for use in scientific apparatus for chemical analysis; reagents for scientific use; reagents for medical research use; genetic identity tests comprised of reagents for non-medical purposes; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria other than for medical or veterinary purposes; nucleic acid sequencing programs other than for medical and veterinary purposes; reagents for research purposes; laboratory reagents for scientific use; nucleic acid amplification reagents other than for medical and veterinary purposes; insemination result control diagnostic reagents for scientific use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 12, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 12, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 12, 2023 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 29, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
REFUSAL PROCESSED BY IB
Oct 4, 2021 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2021 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 15, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 1, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 10, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2021 REPR